KA, B., CE, A., MI, N., & PR, L. (2017). Inhibition of VEGF and Angiopoietin-2 to Reduce Brain Metastases of Breast Cancer Burden. Frontiers in pharmacology, 8, 193. https://doi.org/10.3389/fphar.2017.00193
Chicago Style (17th ed.) CitationKA, Bohn, Adkins CE, Nounou MI, and Lockman PR. "Inhibition of VEGF and Angiopoietin-2 to Reduce Brain Metastases of Breast Cancer Burden." Frontiers in Pharmacology 8 (2017): 193. https://doi.org/10.3389/fphar.2017.00193.
MLA (9th ed.) CitationKA, Bohn, et al. "Inhibition of VEGF and Angiopoietin-2 to Reduce Brain Metastases of Breast Cancer Burden." Frontiers in Pharmacology, vol. 8, 2017, p. 193, https://doi.org/10.3389/fphar.2017.00193.
Warning: These citations may not always be 100% accurate.